POLK DENNIS 4

4 · TD SYNNEX CORP · Filed Jan 13, 2026

Form 4

Period: 2026-01-12

DirectorChair, Hyve Solutions

Transactions

Exercise/Conversion
Common Stock
2026-01-12$106.35/sh+3,997$425,081→ 38,096 total
Exercise/Conversion
Common Stock
2026-01-12$107.32/sh+15,372$1,649,723→ 53,468 total
Exercise/Conversion
Common Stock
2026-01-12$107.32/sh+631$67,719→ 54,099 total
Sale
Common Stock
[F1]
2026-01-12$149.61/sh−7,432$1,111,902→ 46,667 total
Sale
Common Stock
2026-01-12$149.67/sh−631$94,442→ 46,036 total
Sale
Common Stock
[F2]
2026-01-12$150.23/sh−11,937$1,793,296→ 34,099 total
Exercise/Conversion
Stock Option (Right to Buy)
[F3]
2026-01-12−3,997→ 1,985 total
Exercise: $106.35Exp: 2032-01-19→ Common Stock (3,997 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
[F3]
2026-01-12−15,372→ 28,212 total
Exercise: $107.32Exp: 2031-10-05→ Common Stock (15,372 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
[F3]
2026-01-12−631→ 27,581 total
Exercise: $107.32Exp: 2031-10-05→ Common Stock (631 underlying)

Holdings

Footnotes (3)

[F1]Represents the weighted average sales price for a number of transactions effected at prices ranging from $149.38 to $149.95. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
[F2]Represents the weighted average sales price for a number of transactions effected at prices ranging from $150.01 to $150.51. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
[F3]This stock option vests as to 20% of the shares on the first anniversary of the date of grant and vests as to 1/60th of the shares monthly thereafter.

Signature

/s/ Cheryl Grant, attorney-in-fact|2026-01-13

Documents

1 file